Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-11-024589
Filing Date
2011-04-19
Accepted
2011-04-19 15:38:55
Documents
1
Period of Report
2011-04-15

Document Format Files

Seq Description Document Type Size
1 FORM 4 rrd308797.html 4  
1 FORM 4 rrd308797.xml 4 5679
  Complete submission text file 0001181431-11-024589.txt   7107
Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 4152444990
TITAN PHARMACEUTICALS INC (Issuer) CIK: 0000910267 (see all company filings)

EIN.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O TITAN PHARMACEUTICALS INC 400 OYSTER POINT BLVD S SAN FRANCISCO CA 94080
Business Address
MACFARLANE M DAVID (Reporting) CIK: 0001182314 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-27436 | Film No.: 11768007